Diacerein
Diacerein is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| OTC monograph final | 2013-01-07 | |
| 2-oak mix, red/white pollen 3-oak mix, black/blackjack/post pollen 3-ragweed mix, giant/short/western pollen 4-pine mix, austrian/loblolly/scotch/w... | Biologic Licensing Application | 2011-03-11 |
| 4 in 1 pressed mineral spf 15 golden dark | OTC monograph not final | 2011-09-15 |
| 4 in 1 pressed mineral spf 15 medium dark | OTC monograph not final | 2011-09-15 |
| abella | OTC monograph final | 2020-01-17 |
| ailanthus allscale burrobrush burweed marsh elder carelessweed cocklebur common sagebrush curly dock dandelion darkleaves mugwort dog fennel englis... | Biologic Licensing Application | 2009-12-04 |
| aloe up | OTC monograph final | 2020-01-17 |
| aloe up dark tanning oil spf 4 | C200263 | 2024-02-13 |
| anyi beauty 5 seconds remove dark spot cream | C200263 | 2024-04-29 |
| anyi beauty dark spot corrector cream | C200263 | 2024-09-11 |
Show 199 more
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
86 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | — | — | 3 | 7 | 1 | 11 |
| Knee osteoarthritis | D020370 | EFO_0004616 | M17 | — | — | 2 | 5 | — | 7 |
| Gout | D006073 | EFO_0004274 | M10 | — | 2 | — | 1 | — | 3 |
| Fever | D005334 | HP_0001945 | R50.9 | — | — | — | 1 | 2 | 3 |
| Hyperthermia | D000084462 | — | — | — | — | — | 1 | 2 | 3 |
| Pain | D010146 | EFO_0003843 | R52 | — | — | — | 1 | — | 1 |
| Keratoconus | D007640 | EFO_0004223 | H18.6 | — | — | — | 1 | — | 1 |
| Meibomian gland dysfunction | D000080343 | — | H02.88 | — | — | — | 1 | — | 1 |
| Inflammation | D007249 | MP_0001845 | — | — | — | — | 1 | — | 1 |
| Neutropenia | D009503 | — | D70 | — | — | — | 1 | — | 1 |
Show 1 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Diabetes mellitus | D003920 | HP_0000819 | E08-E13 | — | 4 | 1 | — | 3 | 8 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | 4 | 1 | — | 2 | 7 |
| Epidermolysis bullosa | D004820 | — | Q81 | 1 | 4 | 1 | — | — | 5 |
| Epidermolysis bullosa simplex | D016110 | — | Q81.0 | 1 | 3 | 1 | — | — | 4 |
| Liver diseases | D008107 | HP_0002910 | K70-K77 | — | — | 1 | — | — | 1 |
| Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | — | — | 1 | — | — | 1 |
| Fatty liver | D005234 | EFO_0003934 | — | — | — | 1 | — | — | 1 |
| Hip osteoarthritis | D015207 | EFO_1000786 | M16 | — | — | 1 | — | — | 1 |
| Melanoma | D008545 | — | — | — | 1 | 1 | — | — | 1 |
| Uveal neoplasms | D014604 | EFO_1001230 | — | — | 1 | 1 | — | — | 1 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hiv infections | D015658 | EFO_0000764 | B20 | — | 1 | — | — | 2 | 3 |
| Obesity | D009765 | EFO_0001073 | E66.9 | — | 1 | — | — | 2 | 3 |
| Thrombocytopenia | D013921 | HP_0001873 | D69.6 | — | 2 | — | — | — | 2 |
| Diabetes complications | D048909 | — | — | — | 2 | — | — | — | 2 |
| Overweight | D050177 | — | E66.3 | — | 1 | — | — | 1 | 2 |
| Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | — | 1 | — | — | 1 | 2 |
| Schizotypal personality disorder | D012569 | — | F21 | — | 2 | — | — | — | 2 |
| Personality disorders | D010554 | HP_0012075 | F60.6 | — | 2 | — | — | — | 2 |
| Renal insufficiency | D051437 | HP_0000083 | N19 | — | 1 | — | — | — | 1 |
| Viremia | D014766 | — | B34.9 | — | 1 | — | — | — | 1 |
Show 6 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 5 | — | — | — | — | 5 |
| Neoplasms | D009369 | — | C80 | 3 | — | — | — | 1 | 4 |
| Multiple myeloma | D009101 | — | C90.0 | 2 | — | — | — | — | 2 |
| Plasma cell neoplasms | D054219 | — | — | 2 | — | — | — | — | 2 |
| Darier disease | D007644 | Orphanet_218 | E50.8 | 1 | — | — | — | 1 | 2 |
| Pharmacokinetics | D010599 | — | — | 1 | — | — | — | — | 1 |
| Botulism | D001906 | EFO_0005542 | A05.1 | 1 | — | — | — | — | 1 |
| Benign familial pemphigus | D016506 | — | Q82.8 | 1 | — | — | — | — | 1 |
| Epidermolysis bullosa dystrophica | D016108 | — | Q81.2 | 1 | — | — | — | — | 1 |
| Junctional epidermolysis bullosa | D016109 | — | Q81.1 | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hiv | D006678 | — | — | — | — | — | — | 3 | 3 |
| Hypertension | D006973 | EFO_0000537 | I10 | — | — | — | — | 2 | 2 |
| Mental disorders | D001523 | EFO_0000677 | F91.9 | — | — | — | — | 2 | 2 |
| Colorectal neoplasms | D015179 | — | — | — | — | — | — | 2 | 2 |
| Tuberculosis | D014376 | EFO_0000774 | A15-A19 | — | — | — | — | 1 | 1 |
| Highly active antiretroviral therapy | D023241 | — | — | — | — | — | — | 1 | 1 |
| Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | — | — | — | — | 1 | 1 |
| Glucose tolerance test | D005951 | EFO_0004307 | — | — | — | — | — | 1 | 1 |
| Malnutrition | D044342 | EFO_0008572 | E40-E46 | — | — | — | — | 1 | 1 |
| Carcinoma | D002277 | — | C80.0 | — | — | — | — | 1 | 1 |
Show 38 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Diacerein |
| INN | diacerein |
| Description | 4,5-diacetyloxy-9,10-dioxo-2-anthracenecarboxylic acid is an anthraquinone. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O |
Identifiers
| PDB | — |
| CAS-ID | 13739-02-1 |
| RxCUI | — |
| ChEMBL ID | CHEMBL41286 |
| ChEBI ID | — |
| PubChem CID | 26248 |
| DrugBank | DB11994 |
| UNII ID | 4HU6J11EL5 (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 57,098 documents
View more details
Safety
Black-box Warning
Black-box warning for: 2-oak mix, red/white pollen 3-oak mix, black/blackjack/post pollen 3-ragweed mix, giant/short/western pollen 4-pine mix, austrian/loblolly/scotch/w..., Ailanthus allscale burrobrush burweed marsh elder carelessweed cocklebur common sagebrush curly dock dandelion darkleaves mugwort dog fennel englis..., Aranesp, Darvon-n, Symtuza, Urban decay naked skin dark beauty balm spf20
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
174,331 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use